3,4,5-Trimethoxy-N-(6-methyl-3-(phenylthio)pyrido[2,3-b]pyrazin-7-yl)benzamide

ID: ALA4086049

PubChem CID: 137644784

Max Phase: Preclinical

Molecular Formula: C24H22N4O4S

Molecular Weight: 462.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)Nc2cc3ncc(Sc4ccccc4)nc3nc2C)cc(OC)c1OC

Standard InChI:  InChI=1S/C24H22N4O4S/c1-14-17(27-24(29)15-10-19(30-2)22(32-4)20(11-15)31-3)12-18-23(26-14)28-21(13-25-18)33-16-8-6-5-7-9-16/h5-13H,1-4H3,(H,27,29)

Standard InChI Key:  QCSCIRRTWXHGJL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   26.0590  -13.9651    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.7687  -13.5557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7659  -12.7330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0573  -12.3277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3510  -13.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3533  -12.7384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6473  -12.3293    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9387  -12.7369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9403  -13.5577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6469  -13.9631    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4771  -13.9631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4720  -12.3217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2336  -13.9680    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.5229  -13.5845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5264  -12.7694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8185  -12.3626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1108  -12.7729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1154  -13.5943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8238  -13.9975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1813  -12.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8875  -12.3164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1844  -13.5448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.5951  -12.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3008  -12.3151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2982  -11.4971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5839  -11.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8812  -11.5043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5780  -10.2742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2827   -9.8604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0038  -11.0849    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.7136  -11.4899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0098  -12.7214    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0125  -13.5386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  2  0
  2 11  1  0
  3 12  1  0
  9 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 12 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 21  1  0
 26 28  1  0
 28 29  1  0
 25 30  1  0
 30 31  1  0
 24 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4086049

    ---

Associated Targets(Human)

HCC1954 (381 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 462.53Molecular Weight (Monoisotopic): 462.1362AlogP: 4.76#Rotatable Bonds: 7
Polar Surface Area: 95.46Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.78CX LogP: 3.94CX LogD: 3.94
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: -0.98

References

1. Argyros O, Lougiakis N, Kouvari E, Papafotika A, Raptopoulou CP, Psycharis V, Christoforidis S, Pouli N, Marakos P, Tamvakopoulos C..  (2017)  Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activity.,  126  [PMID:28006668] [10.1016/j.ejmech.2016.12.025]

Source